Reverse Payments, Mergers Take Center Stage In Q1
Here are five of the most important decisions of the quarter:
AndroGel Antitrust Litigation
Going after so-called reverse payment settlements in the pharmaceutical industry has been a continuing battle for the Federal Trade Commission and private plaintiffs alike, and the first quarter...
To view the full article, register now.